Skip to content

SODIUM CHLORIDE SOLUTION 0.9%

DRUG14 trials

Sponsors

Moderna Inc., Centre Hospitalier Universitaire De Nice, Daiichi Sankyo Inc., Eli Lilly & Co., Janssen - Cilag International

Conditions

-Peripheral neuropathy clinically defined: *Pure sensitive (lymph node disease) or sensorimotor neuropathies *Proved EMG-Primary Sjögren's syndrome defined as per the European and American criteriaAcute Ischemic StrokeAcute LeukemiaAcute Myeloblastic LeukemiaAcute lower respiratory infectionAtopic dermatitisBreast Cancer Female

Phase 1

Phase 2

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia
CompletedNCT01611116
Goethe UniversityAcute Myeloblastic Leukemia
Start: 2012-05-31End: 2017-04-26Updated: 2023-05-24
J4E-MC-IMMB: A Master Protocol for Randomized, Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis; J4E-MC-FR01: A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of LY3454738 in the Treatment of Adult Patients with Moderate-to-Severe Atopic Dermatitis
CompletedCTIS2022-502888-38-00
Eli Lilly & Co.Atopic dermatitis
Start: 2023-09-25End: 2024-12-11Target: 94Updated: 2024-12-11
A Phase 2, Multicenter, Randomized, Double-blind, Placebo‑controlled Study with Deferred Active Treatment to Investigate the Efficacy, Safety, and Pharmacokinetics of JNJ‑73763989 + Nucleos(t)ide Analog in Participants Co‑infected with Hepatitis B and Hepatitis D Virus
CompletedCTIS2023-506763-33-00
Janssen - Cilag InternationalHepatitis B and Hepatitis D Viral Co-infection
Start: 2020-12-18End: 2025-01-15Target: 14Updated: 2024-09-02
A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Pregnant Women, and Safety, and Immunogenicity in Infants Born to Vaccinated Mothers.
CompletedCTIS2023-505359-37-00
Moderna Inc.Respiratory syncytial virus
Start: 2024-09-03End: 2025-04-30Target: 25Updated: 2025-02-20
Randomised double-blind clinical trial of Onabotulinumtoxin A injection into the corpora cavernosa in patients with erectile dysfunction refractory to treatment with phosphodiesterase-5 inhibitors
RecruitingCTIS2024-514518-10-00
Clinica Universidad De NavarraErectile dysfunction
Start: 2024-10-31Target: 114Updated: 2025-12-29
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial, ADEM2 study
Not yet recruitingCTIS2022-502362-24-00
Centre Hospitalier Universitaire De NiceErosive osteoarthritis
Target: 170Updated: 2025-10-17

Phase 3

Related Papers